Montelukast BE study - Cmax shows supra bioavailability [Regulatives / Guidelines]

posted by elam – Saudi Arabia, 2016-12-04 09:32 (3030 d 10:33 ago) – Posting: # 16830
Views: 9,870

❝ ...really sure about the class 1 thing?

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309826/pdf/12249_2014_Article_241.pdf


Dear All, Thanks for your comments.

Please find the USFDA reference for class I molecule.

https://bpca.nichd.nih.gov/collaborativeefforts/initiatives/documents/formulations_platform_report1.pdf

Complete thread:

UA Flag
Activity
 Admin contact
23,409 posts in 4,921 threads, 1,669 registered users;
23 visitors (0 registered, 23 guests [including 6 identified bots]).
Forum time: 20:05 CET (Europe/Vienna)

Facts are meaningless. You could use facts to prove
anything that’s even remotely true!    Homer Simpson

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5